CME INDIA Downloads
CME INDIA Covid-19 Management Protocol 2021
Last Updated – 17th July 2021.
With the rapid rise in Covid-19 cases in INDIA, CME INDIA has now compiled its own guidelines with inputs from key experts. This document will be updated from time to time, so please check CME INDIA Downloads section regularly.
CME INDIA Covid-19 Vaccination Protocol 2021
Last Updated – 6th July 2021.
Vaccination Saves Lives – With the rapid rise in Covid-19 cases in INDIA, CME INDIA has now compiled its own Vaccination guidelines with inputs from key experts. This document will be updated from time to time, so please check CME INDIA Downloads section regularly.
Diabetes and TB - Challenges in Treatment
In this presentation Dr. D. P. Singh explores the unholy alliance between TB and diabetes, how they both impact the presentation of each other.
Covid-19 Management Guidelines by Narayana Health
Last Updated – 25th May 2021
Narayana Health’s interpretation of managing Covid-19.
A crisp presentation from Dr Pratik Savaj on the current pain point in Covid – Mucormycosis.
SARS CoV 2 Variants and Vaccination
In this presentation, Dr. Mahadev Desai sheds light on the SARS CoV 2 variants, and differences between mutations, variants & strains. Further, he explores the impact of variants; vaccine efficacy vs. effectiveness; vaccinations and breakthrough infections.
COVID-19 Management with New Protocol
A straightforward guide from Professor Soumitra Ghosh to manage Covid-19. It may appear that Covid has an unpredictable course, but it is possible to understand it and manage it.
Quarterly eBulletin on Diabetes April 2021
The quarterly eBulletin on diabetes presented by the Clinical Cardio – Diabetic Society of India.
IAP Covid-19 Management Guidelines
Covid-19 Management for 1 month – 19 years old – Statement by Indian Academy of Pediatrics.
Elderly Diabetic and Peripheral Vascular Disease
If current trends continue, 700 million adults will have diabetes by 2045. PAD and DM may frequently coexist and impose enormous healthcare costs on society. It is important to be able to understand and diagnose each entity alone and together. Dr Sudhir Kumar discusses key points in this presentation.
Intricacies in the Management of Hyperthyroidism
Hyperthyroidism is hyperactivity of thyroid gland with sustained increase in synthesis and release of thyroid hormones. Thyrotoxicosis is the term referred to the physiological effects or clinical syndrome of hypermetabolism that results from excess circulating T3, T4 or both. Presentation by Dr Meena Chabbra.
Management of Type 1 diabetes: Beyond Insulin
Insulin is just one of the things that needs to be managed in Type 1 diabetes. In this presentation Dr Meena Chabbra throws light on all the components that need to be taken into account. Managing Type 1 diabetes is a teamwork that goes beyond diabetologists.
Sotagliflozin in decompensated HF [WHF] and CKD patients
The efficacy and safety of sodium–glucose cotransporter 2 inhibitors such as sotagliflozin in preventing cardiovascular events in patients with diabetes with chronic kidney disease with or without albuminuria have not been well studied. Presentation by Dr Bijay Patni.
Prediabetes A Risk Factor For CVD
Prediabetes is a toxic cardiometabolic state associated with increased risk for microvascular and macrovascular complications. Physicians and healthcare providers should screen patients routinely for prediabetes and refer those with the condition for intensive lifestyle counselling. Presentation by Dr N K Singh.
ESC/EAS 2019 guidelines for the management of Dyslipidemia
The previous ESC/EAS lipid Guidelines were published in August 2016. The emergence of a substantial body of evidence over the last few years has required new, up-to-date Guidelines. Presentation by Dr N K Singh.
AI: The Space-X of Diabetology!
While AI may be a very promising technology, we need to appreciate its limitations. Over-reliance on AI risks de-skilling the profession. Very illuminating presentation from Dr Hem Shankar Sharma.
RSSDI ESI Clinical Practice Guidelines 2020
This important RSSDI presentation from Dr Rajeev Chawla sheds light on the clinical pactice recommendations for the management of type 2 diabetes mellitus.
Diabetes, Covid-19 and Covid Vaccine
This presentation was given by Dr N K Singh on 21st Feb 2021 and discusses the interplay between COVID-19 and Diabetes. It further throws light on COVID vaccination for diabetics.
Clinical pearls in selecting oral antidiabetic drug
This presentation was given by Dr Pratap P Jethwani on 14th Feb 2021 and discusses various oral anti-diabetic drugs.
Exercise in Diabetes
This presentation from 2020 stresses on the fact that any movement is better than none – especially in diabetes. Presented by Dr N K Singh.
When to suspect secondary causes of HTN and How to investigate?
Most patients with hypertension have no clear etiology and are classified as having primary hypertension. However, 5% to 10% of these patients may have secondary hypertension. In this presentation by Dr N K Singh, learn Hypertension and the main screening tests.
40 years of Hypoglycemia Research What have we learnt?
An important compiliation of the key messages that have emerged during the 40 years of research on Hypoglycemia. Presentation by Dr N K Singh.
COVID Management - Time is a game changer
How critical is timing in the management of Covid-19? This presentation from Dr N K Singh explores how right timing – identification of day one of symptoms and initiation of what drugs – can impact COVID treatment.
Management of vasculo-metabolic axis deviation of type 2 diabetes: Role of SGLT2i
Nephrologists and, until recently, cardiologists have not prescribed SGLT2 inhibitors. What changed? See this NEDSCON 2020 presentation by Dr N K Singh to lean more.